Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection
- PMID: 21084664
- DOI: 10.4049/jimmunol.0903452
Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection
Abstract
Infection by the respiratory syncytial virus (RSV) can cause extensive inflammation and lung damage in susceptible hosts due to a Th2-biased immune response. Such a deleterious inflammatory response can be enhanced by immunization with formalin- or UV-inactivated RSV, as well as with vaccinia virus expressing the RSV-G protein. Recently, we have shown that vaccination with rBCG-expressing RSV Ags can prevent the disease in the mouse. To further understand the immunological mechanisms responsible for protection against RSV, we have characterized the T cell populations contributing to virus clearance in mice immunized with this BCG-based vaccine. We found that both CD4(+) and CD8(+) T cells were recruited significantly earlier to the lungs of infected mice that were previously vaccinated. Furthermore, we observed that simultaneous adoptive transfer of CD8(+) and CD4(+) RSV-specific T cells from vaccinated mice was required to confer protection against virus infection in naive recipients. In addition, CD4(+) T cells induced by vaccination released IFN-γ after RSV challenge, indicating that protection is mediated by a Th1 immune response. These data suggest that vaccination with rBCG-expressing RSV Ags can induce a specific effector/memory Th1 immune response consisting on CD4(+) and CD8(+) T cells, both necessary for a fully protective response against RSV. These results support the notion that an effective induction of Th1 T cell immunity against RSV during childhood could counteract the unbalanced Th2-like immune response triggered by the natural RSV infection.
Similar articles
-
Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.Virology. 2000 Mar 30;269(1):54-65. doi: 10.1006/viro.2000.0186. Virology. 2000. PMID: 10725198
-
Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20822-7. doi: 10.1073/pnas.0806244105. Epub 2008 Dec 15. Proc Natl Acad Sci U S A. 2008. PMID: 19075247 Free PMC article.
-
IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.J Immunol. 2009 Dec 1;183(11):7006-13. doi: 10.4049/jimmunol.0900085. Epub 2009 Nov 13. J Immunol. 2009. PMID: 19915054
-
Host immunity during RSV pathogenesis.Int Immunopharmacol. 2008 Oct;8(10):1320-9. doi: 10.1016/j.intimp.2008.03.012. Epub 2008 Apr 14. Int Immunopharmacol. 2008. PMID: 18687294 Review.
-
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review.
Cited by
-
Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System.Front Immunol. 2018 Oct 24;9:2466. doi: 10.3389/fimmu.2018.02466. eCollection 2018. Front Immunol. 2018. PMID: 30405642 Free PMC article. Review.
-
New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.Int J Mol Sci. 2017 Aug 11;18(8):1753. doi: 10.3390/ijms18081753. Int J Mol Sci. 2017. PMID: 28800119 Free PMC article. Review.
-
Role for Gr-1+ cells in the control of high-dose Mycobacterium bovis recombinant BCG.Clin Vaccine Immunol. 2014 Aug;21(8):1120-7. doi: 10.1128/CVI.00363-14. Epub 2014 Jun 11. Clin Vaccine Immunol. 2014. PMID: 24920602 Free PMC article.
-
Analysis of Measles and Rubella Immunoglobulin G Titers in COVID-19 Patients.Risk Manag Healthc Policy. 2024 Nov 14;17:2789-2801. doi: 10.2147/RMHP.S472872. eCollection 2024. Risk Manag Healthc Policy. 2024. PMID: 39558910 Free PMC article.
-
Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette-Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases.Pathogens. 2025 Feb 15;14(2):196. doi: 10.3390/pathogens14020196. Pathogens. 2025. PMID: 40005571 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials